Corvus Pharma
Permanently closed
863 Mitten Rd Ste 102
Burlingame, CA 94010
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company based in Burlingame, California, focused on developing innovative therapies aimed at significantly enhancing the treatment of immune diseases and cancer. Their lead program, oquelitinib, is a first-in-class oral therapy that selectively inhibits ITK to modulate and control parallel signaling pathways within the immune system.
With a commitment to advancing scientific research and improving patient outcomes, Corvus Pharmaceuticals is dedicated to exploring novel approaches in immunotherapy. The company’s pipeline reflects its strategic focus on addressing unmet medical needs in the fields of immune diseases and dermatology.
Also at this address
See a problem?